# Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

> **NCT07352358** · PHASE4 · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 72 (estimated)

## Conditions studied

- Cerebral Venous Thrombosis

## Interventions

- **DRUG:** batroxobin
- **DRUG:** Anticoagulation Agents

## Key facts

- **NCT ID:** NCT07352358
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352358, "Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07352358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*